None of the survivors was actively brittle, and most attributed resolution of brittleness to Talazoparib positive life changes. Total QOL score was lower (i.e. worse) in the brittle compared with the stable group (p=0.046). We conclude that survivors of brittle type 1 diabetes have significant psychosocial morbidity and reduced life quality. This emphasises the adverse long-term effects of brittle diabetes, even when glycaemic stability has been restored. Copyright © 2011 John Wiley & Sons. “
“A significant number of people with type 1 diabetes do not attend their clinic appointments. This study investigated the reasons underlying this decision and explored possible service improvement strategies. This was a cross-sectional

telephone survey among all patients with type 1 diabetes missing at least one appointment at a diabetes clinic between 1 October

2009 and 30 September 2010. Patients were asked two questions: why they did not attend the appointment and how attendance could be improved. The initial ‘did not attend’ (DNA) rate for all appointments was 17.6% (808/4595 appointments). Of these, the largest number were missed by patients (n=252) with type 1 diabetes. After excluding 79 patients no longer under the service, 126/173 (72.8%) were able to be contacted and answered the questions. Forgetting the appointment was the most frequent response (34.9%). Many patients advised not to send appointment reminder letters too far ahead learn more of appointments (12.7%, 16)

and to send a text message reminder (26.2%, 33) two weeks before the appointment. The findings suggest that there is a role for improving the administrative approach to patients’ appointments, reminding patients in advance and improving communication between hospital staff and patients. Copyright © 2012 John Wiley & Sons. “
“With increasing numbers of children being diagnosed with type 1 diabetes at younger ages, and intensification of insulin Alanine-glyoxylate transaminase regimens, many more children require support with their diabetes at primary school. I report here our own experience of setting up a structure for support in schools based on trained volunteers who can supervise or administer insulin with pens or pumps, and who do so based on intensive management including carbohydrate counting and correction doses. There is a clear legal framework to support families asking for help in schools but still no compulsion on schools to provide a member of staff to carry out care, which has to rely on volunteers. We have, however, negotiated a system with our primary care trust and local authority whereby diabetes specialist nurses (DSNs) train up volunteers identified by the school, and, together with the parents, draw up a comprehensive medical management plan. The volunteers are then trained by the DSN, and the parent agrees to go into the school to supervise until both the volunteer and parent are happy that they are competent, when the DSN then goes back into school to certify competence.